(VIANEWS) – PANORO ENERGY (PEN.OL), RYANAIR HOLD. PLC (RYA.IR), SPAREBANKEN ØST (SPOG.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. PANORO ENERGY (PEN.OL)
1233.3% sales growth and 15.08% return on equity
Panoro Energy ASA, an independent exploration and production company, engages in the exploration, development, and production of oil and gas properties in Africa. It holds assets in the Equatorial Guinea, Gabon, Tunisia, and South Africa. The company was incorporated in 2009 and is based in London, the United Kingdom.
Earnings Per Share
As for profitability, PANORO ENERGY has a trailing twelve months EPS of kr3.14.
PE Ratio
PANORO ENERGY has a trailing twelve months price to earnings ratio of 10.13. Meaning, the purchaser of the share is investing kr10.13 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.08%.
More news about PANORO ENERGY.
2. RYANAIR HOLD. PLC (RYA.IR)
38.7% sales growth and 28.82% return on equity
Ryanair Holdings plc, together with its subsidiaries, provides scheduled-passenger airline services in Ireland, the United Kingdom, Italy, Spain, and internationally. It is also involved in the provision of various ancillary services, such as non-flight scheduled and Internet-related services, as well as in-flight sale of beverages, food, duty-free, and merchandise; and markets car hire, travel insurance, and accommodation services through its website and mobile app. In addition, the company offers aircraft and passenger handling, ticketing, and maintenance and repair services; and markets car parking, fast-track, airport transfers, attractions, and activities on its website and mobile app, as well as sells gift vouchers. Ryanair Holdings plc was incorporated in 1996 and is headquartered in Swords, Ireland.
Earnings Per Share
As for profitability, RYANAIR HOLD. PLC has a trailing twelve months EPS of €1.78.
PE Ratio
RYANAIR HOLD. PLC has a trailing twelve months price to earnings ratio of 10.57. Meaning, the purchaser of the share is investing €10.57 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.82%.
Sales Growth
RYANAIR HOLD. PLC’s sales growth for the next quarter is 38.7%.
More news about RYANAIR HOLD. PLC.
3. SPAREBANKEN ØST (SPOG.OL)
18.3% sales growth and 9.08% return on equity
Sparebanken Øst operates as a savings bank in Eastern Norway. The company offers financial products, such as savings, credit, and payment products; current accounts; home mortgage loans; and mortgage loans for new and used cars. It also provides vehicles, houses and contents, boats, and leisure insurance products, as well as life and health insurance products; and shares and funds trading services. In addition, the company buys, sells, and stores cryptocurrencies, as well as operates, manages, leases, and sells real estate properties. The company was founded in 1843 and is headquartered in Drammen, Norway.
Earnings Per Share
As for profitability, SPAREBANKEN ØST has a trailing twelve months EPS of kr7.09.
PE Ratio
SPAREBANKEN ØST has a trailing twelve months price to earnings ratio of 7.52. Meaning, the purchaser of the share is investing kr7.52 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.08%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 21.1% and 3.3%, respectively.
More news about SPAREBANKEN ØST.
4. VISTIN PHARMA (VISTN.OL)
6.6% sales growth and 19.84% return on equity
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. Vistin Pharma ASA was founded in 1969 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr1.27.
PE Ratio
VISTIN PHARMA has a trailing twelve months price to earnings ratio of 18.35. Meaning, the purchaser of the share is investing kr18.35 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.84%.
Moving Average
VISTIN PHARMA’s value is above its 50-day moving average of kr23.01 and above its 200-day moving average of kr23.04.
Yearly Top and Bottom Value
VISTIN PHARMA’s stock is valued at kr23.30 at 02:20 EST, under its 52-week high of kr25.10 and way higher than its 52-week low of kr20.60.
More news about VISTIN PHARMA.
5. AXACTOR (ACR.OL)
5.2% sales growth and 9.72% return on equity
Axactor ASA, through its subsidiaries, operates as a debt management and collection company in Sweden, Finland, Germany, Italy, Norway, and Spain. It operates through two segments: Non-performing Loans and Third-Party Collection. The Non-performing Loans segment invests in portfolios of non-performing loans collected through amicable or legal proceedings. The Third-Party Collection segment provides debt collection services on behalf of third-party clients, which applies amicable and legal proceedings to collect the non-performing loans. This segment is also involved in helping creditors to prepare documentation for future legal proceedings against debtors; and handling of invoices between the invoice date and the default date and sending out reminders. Axactor ASA was incorporated in 1982 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, AXACTOR has a trailing twelve months EPS of kr1.04.
PE Ratio
AXACTOR has a trailing twelve months price to earnings ratio of 4.06. Meaning, the purchaser of the share is investing kr4.06 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.72%.
More news about AXACTOR.
